Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.

Weber SE, Tian H, Pirofski LA.

J Immunol. 2011 Jan 1;186(1):432-42. doi: 10.4049/jimmunol.1001963. Epub 2010 Dec 6.

2.

Inhibition of T cells provides protection against early invasive pneumococcal disease.

LeMessurier K, Häcker H, Tuomanen E, Redecke V.

Infect Immun. 2010 Dec;78(12):5287-94. doi: 10.1128/IAI.00431-10. Epub 2010 Sep 20.

3.

Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.

Roche AM, Weiser JN.

Infect Immun. 2010 May;78(5):2231-9. doi: 10.1128/IAI.01058-09. Epub 2010 Mar 15.

4.

The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.

Richards L, Ferreira DM, Miyaji EN, Andrew PW, Kadioglu A.

Immunobiology. 2010 Apr;215(4):251-63. doi: 10.1016/j.imbio.2009.12.004. Epub 2009 Dec 28.

PMID:
20071053
5.

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006.

Trotter CL, Waight P, Andrews NJ, Slack M, Efstratiou A, George R, Miller E.

J Infect. 2010 Mar;60(3):200-8. doi: 10.1016/j.jinf.2009.12.008. Epub 2009 Dec 23.

PMID:
20035785
6.

The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS.

Infect Immun. 2010 Feb;78(2):704-15. doi: 10.1128/IAI.00881-09. Epub 2009 Nov 30.

7.

Pathogenesis, treatment, and prevention of pneumococcal pneumonia.

van der Poll T, Opal SM.

Lancet. 2009 Oct 31;374(9700):1543-56. doi: 10.1016/S0140-6736(09)61114-4. Review.

PMID:
19880020
8.

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T; Hib and Pneumococcal Global Burden of Disease Study Team.

Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6. Review.

PMID:
19748398
9.

The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia.

Hussell T, Cavanagh MM.

Biochem Soc Trans. 2009 Aug;37(Pt 4):811-3. doi: 10.1042/BST0370811. Review.

PMID:
19614599
10.

Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa.

Khader SA, Gaffen SL, Kolls JK.

Mucosal Immunol. 2009 Sep;2(5):403-11. doi: 10.1038/mi.2009.100. Epub 2009 Jul 8. Review.

11.

Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice.

Zhang Z, Clarke TB, Weiser JN.

J Clin Invest. 2009 Jul;119(7):1899-909. doi: 10.1172/JCI36731. Epub 2009 Jun 8.

12.

Screening of Streptococcus pneumoniae ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis.

Basavanna S, Khandavilli S, Yuste J, Cohen JM, Hosie AH, Webb AJ, Thomas GH, Brown JS.

Infect Immun. 2009 Aug;77(8):3412-23. doi: 10.1128/IAI.01543-08. Epub 2009 May 26.

13.

Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage.

Granat SM, Ollgren J, Herva E, Mia Z, Auranen K, Mäkelä PH.

J Infect Dis. 2009 Jul 1;200(1):99-106. doi: 10.1086/599364.

14.

Pneumococcal vaccination of elderly adults: new paradigms for protection.

Jackson LA, Janoff EN.

Clin Infect Dis. 2008 Nov 15;47(10):1328-38. doi: 10.1086/592691. Review.

15.

Interleukin-17A mediates acquired immunity to pneumococcal colonization.

Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R.

PLoS Pathog. 2008 Sep 19;4(9):e1000159. doi: 10.1371/journal.ppat.1000159.

16.

Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Yuste J, Sen A, Truedsson L, Jönsson G, Tay LS, Hyams C, Baxendale HE, Goldblatt F, Botto M, Brown JS.

Infect Immun. 2008 Aug;76(8):3761-70. doi: 10.1128/IAI.00291-08. Epub 2008 Jun 9.

17.
18.

Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.

Yuste J, Botto M, Bottoms SE, Brown JS.

PLoS Pathog. 2007 Sep 28;3(9):1208-19.

19.

Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.

Zhang Q, Bagrade L, Bernatoniene J, Clarke E, Paton JC, Mitchell TJ, Nunez DA, Finn A.

J Infect Dis. 2007 Apr 15;195(8):1194-202. Epub 2007 Mar 6. Erratum in: J Infect Dis. 2008 May 1;197(9):1354.

20.

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.

Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM.

Nat Immunol. 2007 Apr;8(4):369-77. Epub 2007 Mar 11.

PMID:
17351619
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk